However, the PBPK model includes the mechanisms that affect ADME (such as CYP450 enzymes, glucuronosyltransferases enzymes, transporters such as P-glycoprotein, and breast-cancer resistance proteins). This evidence concerns the gene B3GAT2 and breast carcinoma.